NCT06179303 2026-04-16
Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer
University of Washington
Phase 2 Recruiting
Clinical Trials
12 trialsNCT07466498 2026-03-12
Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Cancer, EQUIP Trial
University of Washington
Phase 2 Not yet recruiting
NCT03941730 2026-03-05
Estradiol in Treating Patients With ER Beta Positive, Triple Negative Locally Advanced or Metastatic Breast Cancer
Mayo Clinic
Phase 2 Active not recruiting
NCT07379502 2026-01-30
Endometrial Response in Polycystic Ovarian Syndrome Treated With Letrozole Alone or With Added Estradiol Valerate
CMH Kharian Medical College
Phase NA Not yet recruiting
NCT01984138 2026-01-28
REVIVE
The Methodist Hospital Research Institute
Phase 2 Active not recruiting
NCT05716516 2026-01-14
ESTHER
Dartmouth-Hitchcock Medical Center
Phase 2 Recruiting
NCT03043924 2025-12-11
MRI-PCOS
University Hospital, Lille
Phase NA Completed
NCT00984399 2025-12-09
Serum Estradiol Levels In Postmenopausal Women With Breast Cancer Receiving Adjuvant Aromatase Inhibitors and Vaginal Estrogen
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT05900895 2025-11-20
PHOEBE
Dartmouth-Hitchcock Medical Center
Phase 1 Recruiting
NCT03401047 2025-08-05
CRM009
University of Virginia
Phase EARLY_PHASE1 Recruiting
NCT03271489 2025-07-22
Long-Term Safety Study of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women
AbbVie
Phase 3 Completed
NCT02238808 2025-06-26
PRESTO
AHS Cancer Control Alberta
Phase 2 Active not recruiting